PVLA
Palvella Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$122.06
-14.54 ▼ -10.64%
🌙 3월 13일 7:35 PM ET (한국 3/14 08:35)
$122.59
+0.53 ▲ +0.43%
| Index | RUT | P/E | - | EPS (ttm) | - | Insider Own | 32.16% | Shs Outstand | 0.01B | Perf Week | -9.17% |
| Market Cap | 1.67B | Forward P/E | - | EPS next Y | -10.23% | Insider Trans | -0.25% | Shs Float | 0.01B | Perf Month | 54.23% |
| Enterprise Value | 1.62B | PEG | - | EPS next Q | -0.91 | Inst Own | 75.12% | Short Float | 21.73% | Perf Quarter | 25.29% |
| Income | - | P/S | - | EPS this Y | 55.07% | Inst Trans | 20.38% | Short Ratio | 5.34 | Perf Half Y | 108.83% |
| Sales | - | P/B | 34.99 | EPS next 5Y | 13.97% | ROA | - | Short Interest | 1.74M | Perf YTD | 16.61% |
| Book/sh | 3.49 | P/C | 26.26 | EPS past 3/5Y | 48.3% 29.42% | ROE | - | 52W High | -19.26% ($151.18) | Perf Year | 349.08% |
| Cash/sh | 4.65 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 569.74% ($18.23) | Perf 3Y | 8.98% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 54.84% | Gross Margin | - | Volatility(W/M) | 7.75% 7.98% | Perf 5Y | -42.21% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 10.21 | Perf 10Y | -13.8% |
| Dividend Ex-Date | - | Quick Ratio | 6.49 | EPS Q/Q | 62.9% | Profit Margin | - | RSI (14) | 53.66 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.49 | Sales Q/Q | - | SMA20 | 2.76% ($118.78) | Beta | -0.25 | Target Price | $224 |
| Payout | - | Debt/Eq | 0.41 | Earnings | 11000000 | SMA50 | 20.58% ($101.23) | Rel Volume | 1.59 | Prev Close | $136.6 |
| Employees | 14 | LT Debt/Eq | 0.41 | EPS/Sales Surpr. | -22.87% - | SMA200 | 76.73% ($69.07) | Avg Volume(3M) | 0.33M | Price | $122.06 |
| IPO | 2015/1/2 | Option/Short | Yes/Yes | Trades | 7186 | Volume | 521,105 | Change | -10.64% |
뉴스 로딩 중...